Psychoplastogens: Rewiring the Brain via Neuroplasticity with Psychedelics

Big picture: Psychoplastogens are a groundbreaking new class of psychoactive compounds that rapidly induce structural and functional changes in the brain, allowing pathological neural circuits to be rewired for therapeutic benefit. Key facts about psychoplastogens: Rapidly increase neural plasticity, unlike traditional antidepressants that work slowly. Produce fast-acting and sustained antidepressant effects in humans after a …

Read more

Ibogaine for Opioid Addiction: Safety Concerns & Cardiac Risks

Ibogaine, an alkaloid derived from the Tabernanthe iboga shrub found in Africa, has received attention as a potential treatment for addiction, particularly opioid use disorder. While small studies have hinted at effectiveness, a new clinical study shows ibogaine comes with concerning safety risks that may limit its therapeutic potential. Key facts: Ibogaine resulted in significant …

Read more

Ayahuasca: A Potential Treatment for Addiction & Psychiatric Disorders?

Ayahuasca is a traditional psychedelic brew from the Amazon that has been used for centuries in shamanic healing rituals. Research is now exploring its potential therapeutic benefits for mental health and addiction. Key Facts: Ayahuasca contains DMT, a hallucinogenic compound, along with MAOIs from the vine Banisteriopsis caapi. The MAOIs allow the DMT to be …

Read more

Psilocybin’s Rapid Anti-Inflammatory Effects (TNF-Alpha, IL-6, CRP) for Depression & Social Benefits

A new study provides evidence that the psychedelic compound psilocybin has both immediate and lasting anti-inflammatory effects in healthy volunteers. The findings shed light on how psilocybin may improve mood, social behavior, and potentially treat depression. Key facts: Psilocybin decreased the inflammatory marker TNF-alpha immediately after administration. Seven days later, psilocybin reduced two other inflammatory …

Read more

Rat Brains on Psychedelics: Hyper-Connectivity Between Regions

Researchers find similarities in brain activity induced by different psychedelic drugs in rats, providing clues to how they alter consciousness. Key facts: Psychedelic drugs like LSD and ketamine induce high-frequency brain waves that synchronize activity across the cortex. This hypersynchrony was seen between the frontal cortex, sensory areas and emotion centers like the ventral striatum. …

Read more

Psychedelics Flatten Brain’s ‘Energy Landscape’ & Increase Neural Diversity, New Study Finds

Researchers have discovered that classic psychedelic drugs like LSD and psilocybin (‘magic mushrooms’) flatten the energy landscape of the brain. This effect makes it easier for the brain to transition between different states of activity and leads to more diverse and entropic neural dynamics overall. Key Facts: Using fMRI data and network modeling, researchers found …

Read more